Divestment
Celladon
Celladon was a clinical-stage biotechnology company advancing gene therapy for cardiovascular disease.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 4
- Entry
2012
- Exit
2015
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.